Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration

NCT: NCT02725762 · COMPLETED

NCT IDNCT02725762
StatusCOMPLETED
SponsorLumiThera, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this research study is to determine if photobiomodulation is an effective treatment of Dry Age-Related Macular Degeneration (AMD) and vision loss associated with the disease.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑